Ainovis SL
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Ainovis SL - overview
Established
2024
Location
Alicante, -, Spain
Primary Industry
Software
About
Based in Spain, Ainovis SL delivers innovative clinical AI solutions that enhance the efficiency of radiology reporting, streamlining workflows for healthcare providers. Ainovis SL, founded in 2024 and headquartered in Alicante, Spain, specializes in developing AI-driven tools for radiology reporting. The company has completed one funding deal, raising EUR 680,000 on May 18, 2026, led by Kunsen VC. Ainovis specializes in clinical AI solutions designed to enhance the efficiency of radiology reporting.
Their primary offering is an AI platform that streamlines report generation, assisting radiologists with automatic template recognition in multiple languages, including Spanish, Portuguese, Italian, French, and German. This platform integrates seamlessly within hospital environments, creating structured clinical reports that meet the needs of healthcare professionals. Ainovis serves various clients, particularly across Europe and Latin America, focusing on reducing reporting times and improving workflow efficiency. Ainovis generates revenue through a subscription-based model, providing access to their AI-driven reporting platform for hospitals and radiology practices.
Clients subscribe to utilize features such as smart template detection and customizable reporting standards, facilitating implementation into existing workflows. Their products are positioned as essential tools for modern radiology, enhancing reporting quality and efficiency. In May 2026, Ainovis SL raised EUR 680,000 in venture funding from Kunsen VC to support their growth initiatives. The company plans to develop new products to further enhance their platform, targeting a launch by the end of 2026.
Additionally, Ainovis aims to expand its market presence into regions beyond Europe and Latin America, specifically targeting the North American market, leveraging their recent funding to facilitate this expansion.
Current Investors
Kunsen VC
Primary Industry
Software
Sub Industries
Analytics & Performance Software, Application Integration Software, Medical Software
Website
www.ainovis.health/
Verticals
Artificial Intelligence, Cloud Computing
Company Stage
Early Stage
Total Amount Raised
Subscriber access only

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.